- Home
- ENLV vs NCZ Comparison
ENLV vs NCZ Comparison
Compare ENLV & NCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENLV | NCZ |
|---|---|---|
| Founded | 2005 | 2003 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.3M | 265.6M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | ENLV | NCZ |
|---|---|---|
| Price | $1.16 | $14.23 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | 466.5K | ★ 533.0K |
| Earning Date | 03-30-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.16% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $2.50 |
| 52 Week High | $2.10 | $3.15 |
Technical Indicators
Market Signals| Indicator | ENLV | NCZ |
|---|---|---|
| Relative Strength Index (RSI) | 62.69 | 48.17 |
| Support Level | $1.01 | $14.43 |
| Resistance Level | $1.26 | $14.62 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 66.17 | 30.00 |
Price Performance
Historical ComparisonAbout ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. The investment objective of the company is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas, and consumable fuels and others.